News
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...
As a doctor and retired Republican congressman, I urge our leaders to double down on life-saving preventive medicine.
8don MSN
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
Novavax said Monday that the Food and Drug Administration was asking the company to run a new clinical trial of its vaccine.
The US Food and Drug Administration will require all new vaccines to undergo placebo-controlled trials before approval — a ...
FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.
The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...
Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...
On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...
“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...
Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results